Evidence map›Paper›PMID 41309876›Full record

ArticleScientific reports2025

Production and trade of specialty coffee in Brazil.

Gustavo Hiroshi Sera, Bruno Volsi, Valdir Mariucci Júnior, Carlos Theodoro Motta Pereira, Tiago Santos Telles

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gustavo Hiroshi SeraInstituto de Desenvolvimento Rural do Paraná - IAPAR-EMATER, Londrina, Brazil.ORCID http://orcid.org/0000-0002-5372-6169
Bruno VolsiInstituto de Desenvolvimento Rural do Paraná - IAPAR-EMATER, Londrina, Brazil.ORCID http://orcid.org/0000-0001-9820-0585
Valdir Mariucci JúniorInstituto de Desenvolvimento Rural do Paraná - IAPAR-EMATER, Londrina, Brazil.ORCID http://orcid.org/0000-0002-2343-3314
Carlos Theodoro Motta PereiraInstituto de Desenvolvimento Rural do Paraná - IAPAR-EMATER, Londrina, Brazil.ORCID http://orcid.org/0000-0002-3168-3129
Tiago Santos TellesInstituto de Desenvolvimento Rural do Paraná - IAPAR-EMATER, Londrina, Brazil. telles@idr.pr.gov.br.ORCID http://orcid.org/0000-0001-5817-3420

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brazil, the world's largest coffee producer and exporter, accounted for one-third of global coffee production in 2022, with a small portion being specialty coffee. This study aims to analyze the production areas, certifications adopted, cultivars used, processing methods, and the production chain of specialty coffee in Brazil, highlighting the challenges and opportunities. Data were collected from 175 farms associated with the Brazilian Specialty Coffee Association (BSCA), and analyzed. The state of Minas Gerais leads in specialty coffee production, supported by a well-structured supply chain. Most Brazilian specialty coffee producers have adopted the semidry processing method, either using this method alone or in combination with other methods. A high frequency of Arabica coffee cultivars with Coffea canephora introgression (e.g., derivatives of Híbrido de Timor and Icatu) was observed on farms, indicating that they have genetic potential for producing specialty coffees. The production of specialty coffees is still limited to a few producers due to the higher costs related to investments in equipment, certification, and traceability. Certifications play a crucial role in ensuring quality and sustainability, addressing environmental, social, and management aspects. These factors are essential for differentiating Brazilian specialty coffees in the global market, increasing their value and its selling price.

Indexed as

AgricultureCoffeaCoffeeCommerceBrazilCoffeeCoffea arabicaCoffee productionSpecialty coffeeSupply-chain

Identifiers

PMID41309876
PMCPMC12660380

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.